论文部分内容阅读
［ 背景］ 肝硬化腹水患者的低钠血症较常见， 但疏于诊治．［ 病例报告］ 对１２８ 例肝硬变腹水患者中合并低血钠的８３ 例（６５ ％ ） 进行分析．其中肝功能ＣｈｉｌｄＰｕｇｈ Ａ 级４４ 例，血钠（１３１－８ ±１－７）ｍ ｍｏｌ／Ｌ；Ｂ级３０ 例，血钠（１２４－７ ±２－９）ｍ ｍｏｌ／Ｌ；Ｃ级９ 例，血钠（１１６－９ ±３－８）ｍ ｍｏｌ／Ｌ．血钠在１３１ ～１３４ｍ ｍｏｌ／Ｌ 之间有３２ 例，死亡２ 例（６ ％ ） ；在１２６ ～１３０ｍ ｍｏｌ／Ｌ 之间有２４ 例，死亡４ 例（１７ ％ ） ；低于１２５ｍ ｍｏｌ／Ｌ２３ 例，死亡８ 例（３２ ％ ） ．［ 讨论］ 血钠浓度在一定程度上可反映肝硬变腹水患者肝功能代偿情况，低血钠与预后有一定关系，血钠程度与死亡率之间存在明显相关性．对肝硬变腹水患者进行综合治疗过程中应密切地监测血钠的变化，及时纠正低血钠，以改善预后
[Background] Hyponatremia in patients with cirrhosis and ascites is more common, but neglected in diagnosis and treatment. [Case Report] Eighty-eight patients (65%) with hyponatremia in cirrhotic patients with cirrhosis were analyzed. Liver function Child-Pugh A class 44 cases, serum sodium (131-8 ± 1-7) m mol / L; B class 30 cases, serum sodium (124-7 ± 2-9) m mol / L; 9 cases, serum sodium (116-9 ± 3-8) m mol / L. Thirty-two cases (6%) died of sodium in 131 ~ 134m mol / L, 24 cases (126%) in 126 ~ 130m mol / Cases, 8 patients died (32%). [Discussion] The serum sodium concentration to a certain extent, can reflect the patients with cirrhosis ascites liver function compensation, hyponatremia and prognosis have a certain relationship between serum sodium level and mortality were significantly correlated. Patients with cirrhosis ascites should be closely monitored in the course of comprehensive treatment of serum sodium changes in a timely manner to correct hyponatremia to improve the prognosis